Electromyographic evidence of subclinical myopathy in hypertrophic cardiomyopathy

Muscle and Nerve

Volumn 23, Issue 12, 2000, Pages 1856-1861

  Karandreas, Nikos ^a   Stathis, Pantelis ^b   Anastasakis, Aris ^c   Rigopoulos, Angelos ^c   Piperos, Panayiotis ^a   Theopistou, Artemis ^c   Stefanadis, Chris ^c   Toutouzas, Pavlos ^c  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b Social Security Foundation   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

Hypertrophic cardiomyopathy; Motor unit potential analysis; Power spectrum; Subclinical myopathy; Turns amplitude

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; ELECTROMYOGRAPHY; FEMALE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; MOTOR UNIT POTENTIAL; MUSCLE BIOPSY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC;

ADOLESCENT; ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC; ELECTROMYOGRAPHY; EVOKED POTENTIALS, MOTOR; FALSE POSITIVE REACTIONS; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MUSCULAR DISEASES; REPRODUCIBILITY OF RESULTS;

EID: 0033646473     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-4598(200012)23:12<1856::AID-MUS9>3.0.CO;2-T     Document Type: Article

References (33)

1. Familial hypertrophic cardiomyopathy - From mutations to functional defects
2. Idiopathic hypertrophic subaortic stenosis. I. A description of the disease based upon an analysis of 64 patients
3. Electromyography in the evaluation of muscle diseases
4. Action potential parameters in different human muscles
5. Type I fiber abnormalities in skeletal muscle of patients with hypertrophic and dilated cardiomyopathy: Evidence of subclinical myogenic myopathy
6. Molecular genetics of familial cardiomyopathies
7. Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic cardiomyopathy
8. Automatic quantitative electromyography
9. Receiver operating curve analysis in the prediction of carpal tunnel syndrome: A model for reporting electrophysiological data
10. Missense mutations in the β-myosin heavy-chain gene causes central core disease in hypertrophic cardiomyopathy
11. Turn/amplitude-analysis in subclinical myogenic lesions
12. EMG power spectrum, turns-amplitude analysis and motor unit potential duration in neuromuscular disorders
13. Evaluation of test data from clinical studies. I. Terminology, graphic interpretation, diagnostic strategies and selection of sample groups. II. Critical review of the concepts of efficacy, receiver operating characteristics (ROC) and likelihood ratios
14. Automatic analysis of the electromyographic interference pattern using the turns: Amplitude ratio
15. The frontiers of cardiomyopathy
16. The recognition of myogenic and neurogenic lesions by quantitative EMG
17. Electromyography in patients with hypertrophic obstractive cardiomyopathy
18. Quantitative expression of morphological characteristics of normal and myopathic EMG of facial muscles
19. Quantitative EMG analysis in myogenic and neurogenic muscle diseases
20. Abnormal contractile properties of muscle fibers expressing β-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy
21. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology and therapy
22. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: Echocardiographic analysis of 4111 subjects in the CARDIA study
23. Experience from clinical genetics in hypertrophic cardiomyopathy: Proposal for new diagnostic criteria in adult members of affected families
24. Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle
25. Report of the 1995 WHO/ISFC task force on the definition and classification of cardiomyopathies
26. Electromyography in normal subjects of different age
27. Voluntary muscle involvement in hypertrophic cardiomyopathy: A study of 11 patients
28. Outliers, a way to detect abnormality in quantitative EMG
29. Automatic analysis of the EMG interference pattern
30. The electromyogram in myopathy: Analysis with the audio-frequency spectrometer
31. Assignment of the human a-tropomyosin gene TPM3 to 1q22-q23 by fluorescence in situ hybridisation
32. Hypertrophic cardiomyopathy mutation is expressed in messenger RNA of skeletal as well as cardiac muscle